Literature DB >> 9504065

Penicillium marneffei infection in patients infected with human immunodeficiency virus.

N Vanittanakom1, T Sirisanthana.   

Abstract

Opportunistic infections are major causes of morbidity in patients with human immunodeficiency virus (HIV) infection. Penicillium marneffei infection is very common in HIV-infected individuals in northern Thailand. The patients usually present with fever, anemia, weight loss, skin lesions, generalized lymphadenopathy, and hepatomegaly. The average number of CD4+ T-lymphocytes at presentation was 63.8 cells/mm3. Diagnosis depends on familiarity with the clinical syndromes and support from the mycology laboratory. The response to antifungal treatment of the patients is generally good, but depends on the ability of the physician to make the diagnosis and start the treatment early. New approaches to the laboratory diagnosis of P. marneffei infection have been reported. Further study of these approaches may help physicians in taking better care of the patients.

Entities:  

Keywords:  Asia; Bacterial And Fungal Diseases; Biology; Dermatological Effects; Developing Countries; Diseases; Examinations And Diagnoses; Hiv Infections; Infections; Laboratory Examinations And Diagnoses; Physiology; Research Methodology; Research Report; Retrospective Studies; Signs And Symptoms; Southeastern Asia; Studies; Thailand; Treatment; Viral Diseases

Mesh:

Year:  1997        PMID: 9504065

Source DB:  PubMed          Journal:  Curr Top Med Mycol        ISSN: 0177-4204


  12 in total

Review 1.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study.

Authors:  Yanyin Ouyang; Shuangqi Cai; Hao Liang; Cunwei Cao
Journal:  Mycopathologia       Date:  2017-01-20       Impact factor: 2.574

3.  Massive hepatosplenomegaly caused by Penicillium marneffei associated with human immunodeficiency virus infection in a Thai patient.

Authors:  A C Bateman; G R Jones; S O'Connell; F J Clark; M Plummeridge
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

4.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

5.  Disseminated Talaromyces marneffei Infection in a Non-HIV Infant With a Homozygous Private Variant of RELB.

Authors:  Xiaofang Ding; Han Huang; Lili Zhong; Min Chen; Fang Peng; Bing Zhang; Xinyu Cui; Xiu-An Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-15       Impact factor: 5.293

6.  Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.

Authors:  Y Cui; C Jin; X Li; Nanping Wu
Journal:  Eur J Med Res       Date:  2011-09-12       Impact factor: 2.175

Review 7.  Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.

Authors:  Tavitiya Sudjaritruk; Thira Sirisanthana; Virat Sirisanthana
Journal:  BMC Infect Dis       Date:  2012-01-31       Impact factor: 3.090

8.  The yapA Encodes bZIP Transcription Factor Involved in Stress Tolerance in Pathogenic Fungus Talaromyces marneffei.

Authors:  Wiyada Dankai; Monsicha Pongpom; Sirida Youngchim; Chester R Cooper; Nongnuch Vanittanakom
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

Review 9.  Adaptation to macrophage killing by Talaromyces marneffei.

Authors:  Monsicha Pongpom; Pramote Vanittanakom; Panjaphorn Nimmanee; Chester R Cooper; Nongnuch Vanittanakom
Journal:  Future Sci OA       Date:  2017-06-30

10.  Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei.

Authors:  Kritsada Pruksaphon; Akarin Intaramat; Kavi Ratanabanangkoon; Joshua D Nosanchuk; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.